#engineering — Monday, January 05, 2026 (1 items)
| 0 | ℹ |
Engineering bispecific exosome activators of T cells to target immune checkpoint inhibitor-resistant metastatic melanoma.
(nature.com)
|
Nature Biotechnology 2026-01-05 | #immunity #cancer #immunotherapy #engineering #exosome |